Statin adjunctive therapy shortens the duration of TB treatment in mice

Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets forMycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases

(2015) Robert N. Mahon et al.   CLINICAL INFECTIOUS DISEASES

Host-directed drug therapy for tuberculosis

(2015) Reto Guler et al.   Nature Chemical Biology

The association between sterilizing activity and drug distribution into tuberculosis lesions

(2015) Brendan Prideaux et al.   NATURE MEDICINE

Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

(2015) Noton K. Dutta et al.   Frontiers in Microbiology

Sterilizing Activity of Thioridazine in Combination with the First-Line Regimen against Acute Murine Tuberculosis

(2014) Noton K. Dutta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis

(2014) Noton K. Dutta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Statins Increase Rifampin Mycobactericidal Effect

(2014) Lívia Silva Lobato et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanism of action of anti-hypercholesterolemia drugs and their resistance

(2014) Vishvanath Tiwari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen

(2014) C. Skerry et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Cutting Edge: Vitamin D Regulates Lipid Metabolism in Mycobacterium tuberculosis Infection

(2014) H. Salamon et al.   JOURNAL OF IMMUNOLOGY

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

(2014) Alimuddin I Zumla et al.   LANCET INFECTIOUS DISEASES

Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation

(2013) Suraj P. Parihar et al.   JOURNAL OF INFECTIOUS DISEASES

MSiReader: An Open-Source Interface to View and Analyze High Resolving Power MS Imaging Files on Matlab Platform

(2013) Guillaume Robichaud et al.   JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials

(2012) Alexios S. Antonopoulos et al.   CURRENT PHARMACEUTICAL DESIGN

Mycobacterium tuberculosis Modulates Macrophage Lipid-Sensing Nuclear Receptors PPAR  and TR4 for Survival

(2012) S. Mahajan et al.   JOURNAL OF IMMUNOLOGY

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence

(2011) N. Andreu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mycobacterium tuberculosis Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-Like Phenotype in Lipid-Loaded Macrophages

(2011) Jaiyanth Daniel et al.   PLoS Pathogens

Mycobacterium Tuberculosis Response to Stress from Reactive Oxygen and Nitrogen Species

(2011) Gyanu Lamichhane   Frontiers in Microbiology

Cholesterol biosynthesis modulation regulates dengue viral replication

(2009) Christopher Rothwell et al.   VIROLOGY

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

(2008) A. Blum et al.   ATHEROSCLEROSIS

Modulation of human T cells signaling transduction by lovastatin

(2008) Shu-Meng Cheng et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY